199 related articles for article (PubMed ID: 31127728)
1. Late onset CMT2A in a Family with an MFN2 Variant: c.2222T>G (p.Leu741Trp).
Lin HP; Ho KWD; Jerath NU
J Neuromuscul Dis; 2019; 6(2):259-261. PubMed ID: 31127728
[TBL] [Abstract][Full Text] [Related]
2. Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations.
Chung KW; Kim SB; Park KD; Choi KG; Lee JH; Eun HW; Suh JS; Hwang JH; Kim WK; Seo BC; Kim SH; Son IH; Kim SM; Sunwoo IN; Choi BO
Brain; 2006 Aug; 129(Pt 8):2103-18. PubMed ID: 16835246
[TBL] [Abstract][Full Text] [Related]
3. A mutation in the heptad repeat 2 domain of MFN2 in a large CMT2A family.
Dankwa L; Richardson J; Motley WW; Züchner S; Scherer SS
J Peripher Nerv Syst; 2018 Mar; 23(1):36-39. PubMed ID: 29341354
[TBL] [Abstract][Full Text] [Related]
4. A cohort study of MFN2 mutations and phenotypic spectrums in Charcot-Marie-Tooth disease 2A patients.
Choi BO; Nakhro K; Park HJ; Hyun YS; Lee JH; Kanwal S; Jung SC; Chung KW
Clin Genet; 2015 Jun; 87(6):594-8. PubMed ID: 24863639
[TBL] [Abstract][Full Text] [Related]
5. Clinical and genetic diversities of Charcot-Marie-Tooth disease with MFN2 mutations in a large case study.
Ando M; Hashiguchi A; Okamoto Y; Yoshimura A; Hiramatsu Y; Yuan J; Higuchi Y; Mitsui J; Ishiura H; Umemura A; Maruyama K; Matsushige T; Morishita S; Nakagawa M; Tsuji S; Takashima H
J Peripher Nerv Syst; 2017 Sep; 22(3):191-199. PubMed ID: 28660751
[TBL] [Abstract][Full Text] [Related]
6. Genetic epidemiology of Charcot-Marie-Tooth disease.
Braathen GJ
Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
[TBL] [Abstract][Full Text] [Related]
7. Late-onset hereditary sensory and autonomic neuropathy expands the phenotypic spectrum of MFN2-related diseases.
Wu R; Fu J; Meng L; Lv H; Wang Z; Yuan Y
Neuropathology; 2018 Oct; 38(5):463-467. PubMed ID: 30011089
[TBL] [Abstract][Full Text] [Related]
8. Charcot-Marie-Tooth disease type 2A: from typical to rare phenotypic and genotypic features.
Bombelli F; Stojkovic T; Dubourg O; Echaniz-Laguna A; Tardieu S; Larcher K; Amati-Bonneau P; Latour P; Vignal O; Cazeneuve C; Brice A; Leguern E
JAMA Neurol; 2014 Aug; 71(8):1036-42. PubMed ID: 24957169
[TBL] [Abstract][Full Text] [Related]
9. A cohort study of Han Chinese MFN2-related Charcot-Marie-Tooth 2A.
Lv H; Wang L; Zhang W; Wang Z; Zuo Y; Liu J; Yuan Y
J Neurol Sci; 2015 Nov; 358(1-2):153-7. PubMed ID: 26382835
[TBL] [Abstract][Full Text] [Related]
10. Novel MFN2 Missense Mutation Induces Hereditary Axonal Motor and Sensory Neuropathy in a Saudi Arabian Family.
Al-Harbi TM; Abdulmana SO; Bashir S; Dridi W
J Clin Neuromuscul Dis; 2019 Sep; 21(1):25-29. PubMed ID: 31453851
[TBL] [Abstract][Full Text] [Related]
11. A novel homozygous MFN2 mutation associated with severe and atypical CMT2 phenotype.
Iapadre G; Morana G; Vari MS; Pinto F; Lanteri P; Tessa A; Santorelli FM; Striano P; Verrotti A
Eur J Paediatr Neurol; 2018 May; 22(3):563-567. PubMed ID: 29361379
[TBL] [Abstract][Full Text] [Related]
12. Early onset Charcot-Marie-Tooth neuropathy type 2A and severe developmental delay: expanding the clinical phenotype of MFN2-related neuropathy.
Tufano M; Cappuccio G; Terrone G; Manganelli F; Pisciotta C; Geroldi A; Capponi S; Del Giudice E
J Peripher Nerv Syst; 2015 Dec; 20(4):415-8. PubMed ID: 26307494
[TBL] [Abstract][Full Text] [Related]
13. Mosaicism for a pathogenic MFN2 mutation causes minimal clinical features of CMT2A in the parent of a severely affected child.
Schon K; Spasic-Boskovic O; Brugger K; Graves TD; Abbs S; Park SM; Ambegaonkar G; Armstrong R
Neurogenetics; 2017 Jan; 18(1):49-55. PubMed ID: 28063088
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial Dysfunction and Pharmacodynamics of Mitofusin Activation in Murine Charcot-Marie-Tooth Disease Type 2A.
Franco A; Dang X; Zhang L; Molinoff PB; Dorn GW
J Pharmacol Exp Ther; 2022 Nov; 383(2):137-148. PubMed ID: 36507849
[TBL] [Abstract][Full Text] [Related]
15. Charcot-Marie-Tooth disease type 2A with an autosomal-recessive inheritance: the first report of an adult-onset disease.
Hikiami R; Yamashita H; Koita N; Jingami N; Sawamoto N; Furukawa K; Kawai H; Terashima T; Oka N; Hashiguchi A; Takashima H; Urushitani M; Takahashi R
J Hum Genet; 2018 Jan; 63(1):89-92. PubMed ID: 29215088
[TBL] [Abstract][Full Text] [Related]
16. Homozygous Mutations in
Asif M; Chiou CC; Hussain MF; Hussain M; Sajid Z; Gulsher M; Raheem A; Khan A; Nasreen N; Kloczkowski A; Hassan M; Iqbal F; Chen CC
DNA Cell Biol; 2023 Nov; 42(11):697-708. PubMed ID: 37797217
[TBL] [Abstract][Full Text] [Related]
17. A novel double mutation in cis in MFN2 causes Charcot-Marie-Tooth neuropathy type 2A.
Park SY; Kim SY; Hong YH; Cho SI; Seong MW; Park SS
Neurogenetics; 2012 Aug; 13(3):275-80. PubMed ID: 22526351
[TBL] [Abstract][Full Text] [Related]
18. A late-onset and mild form of Charcot-Marie-Tooth disease type 2 caused by a novel splice-site mutation within the Mitofusin-2 gene.
Kotruchow K; Kabzińska D; Hausmanowa-Petrusewicz I; Kochański A
Acta Myol; 2013 Dec; 32(3):166-9. PubMed ID: 24803844
[TBL] [Abstract][Full Text] [Related]
19. Mutational mechanisms in MFN2-related neuropathy: compound heterozygosity for recessive and semidominant mutations.
Piscosquito G; Saveri P; Magri S; Ciano C; Di Bella D; Milani M; Taroni F; Pareyson D
J Peripher Nerv Syst; 2015 Dec; 20(4):380-6. PubMed ID: 26306937
[TBL] [Abstract][Full Text] [Related]
20. A novel mutation of the MFN2 gene in a Chinese family with Charcot-Marie-Tooth disease.
Wang YW; Han WT; Jiang M; Lu CX; Li XF; Zhang X; Li JX
Genet Mol Res; 2012 May; 11(2):1454-9. PubMed ID: 22653593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]